Baxter Spends Big on ApaTech to Join Orthobiologics Fray
Executive Summary
Baxter International Inc. brought its full and considerable weight to bear to the orthobiologics market by paying handsomely for Apatech Inc., a privately held start-up with a silicate substituted calcium phosphate synthetic bone graft material.